ArriVent BioPharma, Inc (NASDAQ:AVBP) IPO will take place January, 26 on the NASDAQ exchange under the ticker AVBP.
The company is offering shares at an expected price between $17.00 and $19.00 per share with an insider lock-up period of 180 days ending on July 24, 2024.
See also: Benzinga IPO Calendar
About ArriVent BioPharma, Inc
ArriVent BioPharma, Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers
See also: Benzinga’s Most Shorted Stocks
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
